Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC- restricted and MHC-regulated; a model for MHC-disease associations

doi:10.1084/jem.164.3.723

This Article

	Full Text (PDF, 1063K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Kast, W. M.
	Articles by Melief, C. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Kast, W. M.
	Articles by Melief, C. J.


Social Bookmarking

	What's this?

ARTICLES

Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC- restricted and MHC-regulated; a model for MHC-disease associations

WM Kast, AM Bronkhorst, LP de Waal and CJ Melief

The in vivo importance of class I MHC regulation of the Tc response to a natural pathogenic agent of high virulence was studied on the basis of our previous demonstration of a major difference in the capacity to generate a Sendai virus-specific Tc response between C57BL/6 (B6, H-2b) mice and H-2Kb mutant B6.C-H-2bm1 (bm 1) mice. These two mouse strains differ from each other only in three amino acids in the crucial H-2Kb restriction element for this response. bm 1 mice, in contrast to B6 mice, are Tc nonresponders against this virus, but show Sendai-specific T cell proliferation, antibody production, and DTH reactions, as well as NK cell activity, equal to those of B6 mice. B6, Sendai Tc-deficient bm 1 and T cell-deficient B6 nu/nu mice differ from each other in susceptibility to lethal pneumonia induced by i.n. inoculation of virulent Sendai virus. The lethal dose (LD50) in B6 mice averaged 152 TCID50, in bm 1 mice, 14 TCID50 and in B6 nu/nu mice 0.5 TCID50. The importance of Tc was also shown by the complete protection of B6 nu/nu mice against infection with a lethal virus dose by i.v. injection of a Sendai virus-specific, IL-2-dependent and H-2Kb-restricted B6 Tc clone. In vivo protection by this Tc clone was H-2Kb-restricted. Apart from Tc, an important role for virus-specific Th cells is evident from the difference in susceptibility between bm 1 and B6 nu/nu mice. This conclusion was supported by the demonstration that the mean survival time of B6 nu/nu and bm 1 nu/nu mice could be significantly prolonged, in an I-Ab-restricted manner, by the injection of in vitro-propagated, Sendai-specific B6 or bm 1 Th clones after a lethal dose of Sendai virus, and by the demonstration that inoculation of these Th clones provided help to virus-specific Tc by means of IL-2 production. Strikingly, Th and Tc cooperate in anti-Sendai virus immunity, since permanent survival of lethally infected nu/nu mice was only achieved by inoculation of a mixture of Tc and Th clones or a mixture of a Tc clone and rIL-2. This study provides a unique model for the study of MHC- disease associations.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Yee, C. (2009). Adoptive T Cell Therapy: Stratagems and Spoils. Am Soc Clin Oncol Ed Book 2009: 511-515 [Abstract] [Full Text]
Behrens, G. M. N., Li, M., Davey, G. M., Allison, J., Flavell, R. A., Carbone, F. R., Heath, W. R. (2004). Helper Requirements for Generation of Effector CTL to Islet {beta} Cell Antigens. J. Immunol. 172: 5420-5426 [Abstract] [Full Text]
Henrickson, K. J. (2003). Parainfluenza Viruses. Clin. Microbiol. Rev. 16: 242-264 [Abstract] [Full Text]
Zwaveling, S., Vierboom, M. P. M., Ferreira Mota, S. C., Hendriks, J. A., Ooms, M. E., Sutmuller, R. P. M., Franken, K. L. M. C., Nijman, H. W., Ossendorp, F., van der Burg, S. H., Offringa, R., Melief, C. J. M. (2002). Antitumor Efficacy of Wild-Type p53-specific CD4+ T-Helper Cells. Cancer Res. 62: 6187-6193 [Abstract] [Full Text]
Zwaveling, S., Mota, S. C. F., Nouta, J., Johnson, M., Lipford, G. B., Offringa, R., van der Burg, S. H., Melief, C. J. M. (2002). Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides. J. Immunol. 169: 350-358 [Abstract] [Full Text]
Hogan, R. J., Zhong, W., Usherwood, E. J., Cookenham, T., Roberts, A. D., Woodland, D. L. (2001). Protection from Respiratory Virus Infections Can Be Mediated by Antigen-Specific Cd4+ T Cells That Persist in the Lungs. JEM 193: 981-986 [Abstract] [Full Text]
Jager, E., Jager, D., Karbach, J., Chen, Y.-T., Ritter, G., Nagata, Y., Gnjatic, S., Stockert, E., Arand, M., Old, L. J., Knuth, A. (2000). Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101-0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1-Expressing Melanoma. JEM 191: 625-630 [Abstract] [Full Text]
Hoft, D. F., Schnapp, A. R., Eickhoff, C. S., Roodman, S. T. (2000). Involvement of CD4+ Th1 Cells in Systemic Immunity Protective against Primary and Secondary Challenges with Trypanosoma cruzi. Infect. Immun. 68: 197-204 [Abstract] [Full Text]
Toes, R. E.M., Ossendorp, F., Offringa, R., Melief, C. J.M. (1999). CD4 T Cells and Their Role in Antitumor Immune Responses. JEM 189: 753-756 [Full Text]
Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., Nakano, H. (1999). Mice Lacking Expression of Secondary Lymphoid Organ Chemokine Have Defects in Lymphocyte Homing and Dendritic Cell Localization. JEM 189: 451-460 [Abstract] [Full Text]
Foon, K. A., Yannelli, J., Bhattacharya-Chatterjee, M. (1999). Colorectal Cancer as a Model for Immunotherapy. Clin. Cancer Res. 5: 225-236 [Full Text]
Hiranuma, K, Tamaki, S, Nishimura, Y, Kusuki, S, Isogawa, M, Kim, G, Kaito, M, Kuribayashi, K, Adachi, Y, Yasutomi, Y (1999). Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus. J. Gen. Virol. 80: 187-193 [Abstract]
Smith, P. M., Zhang, Y., Jennings, S. R., O'Callaghan, D. J. (1998). Characterization of the Cytolytic T-Lymphocyte Response to a Candidate Vaccine Strain of Equine Herpesvirus 1�in CBA Mice. J. Virol. 72: 5366-5372 [Abstract] [Full Text]
Saron, M. F., Fayolle, C., Sebo, P., Ladant, D., Ullmann, A., Leclerc, C. (1997). Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis�virus. Proc. Natl. Acad. Sci. USA 94: 3314-3319 [Abstract] [Full Text]
Kundig, T., Schorle, H, Bachmann, M., Hengartner, H, Zinkernagel, R., Horak, I (1993). Immune responses in interleukin-2-deficient mice. Science 262: 1059-1061 [Abstract]
Melief, C.J.M., Vasmel, W.L.E., Offringa, R., Sijts, E.J.A.M., Matthews, E.A., Peters, P.J., Meloen, R.H., van der Eb, A.J., Kast, W.M. (1989). Immunosurveillance of Virus-induced Tumors. Cold Spring Harb Symp Quant Biol 54: 597-603 [Abstract]